ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly total inventories, gross (FIFO cost before LIFO reserve, $M) ($M)
Form 10-Q / 10-K Inventories Note
Latest, Q2 2026
16,755
Period ended Jun 30, 2026
Change on a year earlier
+52.1%
11,015 in Q2 2025
History
18 quarters
Since Q4 2016
Sources
17
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total inventories, gross (FIFO cost before LIFO reserve, $M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 16,755 | +52.1% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 14,492 | +56.1% | Form 10-Q (filed 2026-04-30) ↗ |
| Q4 2025 | Dec 31, 2025 | 13,701 | +82.0% | Form 10-Q (filed 2026-08-05) ↗ |
| Q3 2025 | Sep 30, 2025 | 12,219 | +65.4% | Form 10-Q (filed 2025-10-30) ↗ |
| Q2 2025 | Jun 30, 2025 | 11,015 | +72.3% | Form 10-Q (filed 2025-08-07) ↗ |
| Q1 2025 | Mar 31, 2025 | 9,282 | +54.6% | Form 10-Q (filed 2025-05-01) ↗ |
| Q4 2024 | Dec 31, 2024 | 7,526 | +32.7% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2024 | Sep 30, 2024 | 7,386 | – | Form 10-Q (filed 2024-10-30) ↗ |
| Q2 2024 | Jun 30, 2024 | 6,394 | – | Form 10-Q (filed 2024-08-08) ↗ |
| Q1 2024 | Mar 31, 2024 | 6,005 | – | Form 10-Q (filed 2024-04-30) ↗ |
| Q4 2023 | Dec 31, 2023 | 5,670 | +31.8% | Form 10-K (filed 2025-02-19) ↗ |
| Q4 2022 | Dec 31, 2022 | 4,301 | +11.7% | Form 10-K (filed 2024-02-21) ↗ |
| Q4 2021 | Dec 31, 2021 | 3,852 | -2.4% | Form 10-K (filed 2023-02-22) ↗ |
| Q4 2020 | Dec 31, 2020 | 3,946 | +25.7% | Form 10-K (filed 2022-02-23) ↗ |
| Q4 2019 | Dec 31, 2019 | 3,140 | +2.5% | Form 10-K (filed 2021-02-17) ↗ |
| Q4 2018 | Dec 31, 2018 | 3,062 | -30.4% | Form 10-K (filed 2020-02-19) ↗ |
| Q4 2017 | Dec 31, 2017 | 4,398 | +24.2% | Form 10-K (filed 2019-02-19) ↗ |
| Q4 2016 | Dec 31, 2016 | 3,540 | – | Form 10-K (filed 2018-02-20) ↗ |
Breakdown
What makes up total inventories, gross (fifo cost before lifo reserve, $m)
Cite this data
StockData. (2026). Eli Lilly Total inventories, gross (FIFO cost before LIFO reserve, $M) ($M), quarterly Q4 2016–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/inv_gross
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.